Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

ClinicalTrials.gov ID: NCT05648110

Public ClinicalTrials.gov record NCT05648110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/III Randomized, Double-blind Study to Evaluate the Safety, Efficacy and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants With Conditions Causing Immune Impairment. Sub-study: Phase II Open Label Sub-study to Evaluate the Safety, PK, and Neutralizing Activity of AZD3152 for Pre-exposure Prophylaxis of COVID-19

Study identification

NCT ID
NCT05648110
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
3,882 participants

Conditions and interventions

Interventions

  • AZD3152 (Parent study Main Cohort) Biological
  • AZD3152 (Sub-study) Biological
  • AZD5156 (Parent study Sentinel Safety Cohort) Biological
  • AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152 Biological
  • AZD7442 - EVUSHELD™ (Sub-study) Biological
  • EVUSHELD™ (Parent study Main Cohort) Biological
  • Placebo (Parent study Main Cohort) Biological
  • Placebo (Parent study Sentinel Safety Cohort) Biological

Biological

Eligibility (public fields only)

Age range
12 Years to 130 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2022
Primary completion
Mar 28, 2024
Completion
Feb 10, 2025
Last update posted
Mar 12, 2025

2022 – 2025

United States locations

U.S. sites
130
U.S. states
39
U.S. cities
111
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Birmingham Alabama 35215
Research Site Mobile Alabama 36608
Research Site Glendale Arizona 85306
Research Site Mesa Arizona 85206
Research Site Mesa Arizona 85210
Research Site Tucson Arizona 85712
Research Site Little Rock Arkansas 72205
Research Site Colton California 92324
Research Site La Mesa California 91942
Research Site Long Beach California 90815
Research Site Los Angeles California 90027
Research Site Modesto California 95350
Research Site Sacramento California 95817
Research Site Tustin California 92780
Research Site Westminster California 92683
Research Site Aurora Colorado 80014
Research Site Denver Colorado 80209
Research Site Denver Colorado 80246
Research Site Fort Collins Colorado 80525
Research Site New Haven Connecticut 06519
Research Site Washington D.C. District of Columbia 20007
Research Site Coral Gables Florida 33134
Research Site Fleming Island Florida 32003
Research Site Fort Myers Florida 33912
Research Site Hollywood Florida 33024
Research Site Jacksonville Florida 32216
Research Site Jacksonville Florida 32256
Research Site Lake Worth Florida 33462
Research Site Largo Florida 33777
Research Site Lauderdale Lakes Florida 33313
Research Site Leesburg Florida 34748
Research Site Medley Florida 33166
Research Site Miami Florida 33125
Research Site Miami Florida 33126
Research Site Miami Florida 33135
Research Site Miami Florida 33186
Research Site Miami Lakes Florida 33014
Research Site Miami Springs Florida 33166
Research Site North Miami Beach Florida 33162
Research Site Orlando Florida 32806
Research Site Ormond Beach Florida 32174
Research Site Port Orange Florida 32127
Research Site St. Petersburg Florida 33713
Research Site Winter Park Florida 32789
Research Site Atlanta Georgia 30342
Research Site Columbus Georgia 31904
Research Site Boise Idaho 83712
Research Site Burr Ridge Illinois 60527
Research Site Chicago Illinois 60612
Research Site Chicago Illinois 60640
Research Site Gurnee Illinois 60031
Research Site Evansville Indiana 47712
Research Site Evansville Indiana 47715
Research Site South Bend Indiana 46617
Research Site West Des Moines Iowa 50266
Research Site Overland Park Kansas 66204
Research Site Wichita Kansas 67214
Research Site Bowling Green Kentucky 42101
Research Site Lexington Kentucky 40503
Research Site Lexington Kentucky 40509
Research Site Lake Charles Louisiana 70605
Research Site Metairie Louisiana 70006
Research Site New Orleans Louisiana 70119
Research Site Baltimore Maryland 21287
Research Site Boston Massachusetts 02115
Research Site Boston Massachusetts 02215
Research Site Methuen Massachusetts 01844
Research Site Springfield Massachusetts 01107
Research Site Worcester Massachusetts 01655
Research Site Detroit Michigan 48202
Research Site Farmington Hills Michigan 48334
Research Site Grand Rapids Michigan 49525
Research Site Novi Michigan 48377
Research Site Saint Clair Shores Michigan 48081
Research Site Minneapolis Minnesota 55446
Research Site Jefferson City Missouri 65109
Research Site Kansas City Missouri 64114
Research Site St Louis Missouri 63110
Research Site St Louis Missouri 63131
Research Site Missoula Montana 59808
Research Site Lincoln Nebraska 68516
Research Site Las Vegas Nevada 89119
Research Site Portsmouth New Hampshire 03801
Research Site Hackensack New Jersey 07601
Research Site Albuquerque New Mexico 87109
Research Site Buffalo New York 14202
Research Site Ridgewood New York 11385
Research Site Rochester New York 14607
Research Site Rochester New York 14642
Research Site Charlotte North Carolina 28208
Research Site Durham North Carolina 27710
Research Site Monroe North Carolina 28112
Research Site Morehead City North Carolina 28557
Research Site Wilmington North Carolina 28403
Research Site Cincinnati Ohio 45267
Research Site Westlake Ohio 44145
Research Site Allentown Pennsylvania 18103
Research Site Duncansville Pennsylvania 16635
Research Site Harrisburg Pennsylvania 17110
Research Site Philadelphia Pennsylvania 19104
Research Site Philadelphia Pennsylvania 19107
Research Site Pittsburgh Pennsylvania 15232
Research Site Providence Rhode Island 02903
Research Site Myrtle Beach South Carolina 29572
Research Site North Charleston South Carolina 29405
Research Site Rock Hill South Carolina 29732
Research Site Spartanburg South Carolina 29303
Research Site Knoxville Tennessee 37909
Research Site Austin Texas 78745
Research Site Dallas Texas 75246
Research Site El Paso Texas 79925
Research Site Houston Texas 77054
Research Site Houston Texas 77065
Research Site Houston Texas 77070
Research Site Houston Texas 77081
Research Site Houston Texas 77089
Research Site Kingwood Texas 77339
Research Site Mesquite Texas 75150
Research Site San Angelo Texas 76904
Research Site San Antonio Texas 78229
Research Site Shenandoah Texas 77384
Research Site Layton Utah 84041
Research Site Salt Lake City Utah 84115
Research Site Annandale Virginia 22003
Research Site Norfolk Virginia 23502
Research Site Norfolk Virginia 23507
Research Site Olympia Washington 98506
Research Site Seattle Washington 98109
Research Site Madison Wisconsin 53715

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05648110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05648110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →